Three years ago, I sat across from a founder who was about to make the same mistake I made with we analyzed 10,000 clinical trials: ai predicts drug. I told them the truth.
I've been in the Silicon Valley trenches for over a decade, and I've never seen a shift as massive as AI in healthcare. I'm sharing the hard-won lessons from my own startups and investments—the wins, the failures, and the counterintuitive strategies that actually work.
The Counterintuitive Truth
Here's what surprised me most about we analyzed 10,000 clinical trials: ai predicts drug: the best practitioners do less, not more.
When I was building MovieLaLa, we tried to do everything at once. We had the best technology, the smartest team, and we still almost failed because we spread ourselves too thin.
The lesson I took from that experience, and from watching hundreds of other companies, is that you should focus on one thing and do it exceptionally well. It sounds simple. It's incredibly hard to execute.
The Framework That Actually Works
I'm going to share the exact framework I use when evaluating we analyzed 10,000 clinical trials: ai predicts drug. It's not complicated, but it requires discipline.
Step 1: you need to move fast and break things This is where most people go wrong. They skip this step entirely and jump straight to execution. Don't do that.
Step 2: you should focus on one thing and do it exceptionally well Once you have the foundation right, this becomes much easier. I've watched founders struggle with this for months when the answer was staring them in the face.
Step 3: Iterate relentlessly Nothing works perfectly the first time. The companies in my portfolio that nail we analyzed 10,000 clinical trials: ai predicts drug are the ones that treat it as an ongoing process, not a one-time project.
What I've Learned From 103 Companies
After investing in 200+ startups and running two companies to successful exits, I've developed a pretty clear picture of what works with we analyzed 10,000 clinical trials: ai predicts drug.
The biggest misconception is that you need to you need to move fast and break things. That's backwards. The companies that win are the ones that customer feedback is the only metric that matters.
I remember sitting with the Anthropic team early on and discussing how they thought about we analyzed 10,000 clinical trials: ai predicts drug. Their approach was counterintuitive but brilliant.
The AI Angle
I can't talk about we analyzed 10,000 clinical trials: ai predicts drug in 2026 without mentioning AI. As someone who's invested in Anthropic, OpenAI, Scale AI, and Hugging Face, I have a front-row seat to how AI is transforming this space.
The short version: AI makes good practitioners better and bad practitioners worse. It's an amplifier, not a replacement.
I've seen companies use AI to 10x their we analyzed 10,000 clinical trials: ai predicts drug capabilities. I've also seen companies waste millions on AI solutions that solved the wrong problem. The difference comes down to understanding what you're actually trying to achieve.
This connects to broader themes around healthcare automation, AI mental health, drug discovery AI, AI radiology, clinical AI that I've been thinking about a lot lately.
Final Thoughts
After two exits, 200+ investments, and more mistakes than I can count, here's what I know for sure about we analyzed 10,000 clinical trials: ai predicts drug: there are no shortcuts, but there are smarter paths.
The smartest founders I work with treat we analyzed 10,000 clinical trials: ai predicts drug as a competitive advantage, not a checkbox. They invest in it early, measure it obsessively, and never stop improving.
If you're just getting started with we analyzed 10,000 clinical trials: ai predicts drug, don't be intimidated. Everyone starts somewhere. The key is to start with the right mindset and the right framework, and then execute like your company depends on it. Because it probably does.
Frequently Asked Questions
What's the most common pushback you get on this?
People often push back by citing exceptions or edge cases. And they're usually right that exceptions exist. But building a strategy around exceptions rather than patterns is a losing game for most founders.
How has this view evolved over time?
My thinking on most topics has changed significantly over the years. Early in my career, I held many conventional views that experience proved wrong. I try to update my beliefs when the evidence changes.
How can I apply this thinking to my own situation?
Start by identifying the core principle behind the opinion, not the specific example. Then ask yourself: does this principle apply to my context? If yes, test it in a small, low-risk way before going all in.
What experience informs this perspective?
This perspective comes from over a decade of building companies in Silicon Valley, two successful exits (RemoteTeam to Gusto, MovieLaLa to Gfycat), and investing in 200+ startups including Anthropic, OpenAI, and Scale AI. I write about what I've lived.